Seguridad y contraindicaciones

Descargo de responsabilidad general: Proporcionamos información sobre nuestros dispositivos médicos y de bienestar. Si bien hacemos todo lo posible para asegurarnos de que la información sea precisa e informativa, la información no reemplaza el consejo médico o profesional. Esta información es sólo para fines generales. Proporcionar esta información no constituye la práctica de la medicina, la enfermería u otros servicios profesionales de atención médica, incluida la prestación de asesoramiento médico. No se forma ninguna relación médico-paciente. El uso de esta información o cualquier material de nuestro sitio web o materiales de marketing se basa en ensayos clínicos, manuscritos revisados ​​por pares y la experiencia de nuestros clientes y puede no ser relevante para algunas circunstancias individuales. En consecuencia, esta información no pretende sustituir el asesoramiento, diagnóstico o tratamiento profesional. Los usuarios no deben ignorar ni retrasar la obtención de asesoramiento médico para cualquier afección médica que puedan tener, y deben buscar el consejo de sus profesionales de la salud en caso de dicha afección.

Todos los clientes deben tener cierto nivel de precaución, especialmente aquellos con comorbilidades (consulte la tabla a continuación), al utilizar cualquier forma de fototerapia, incluido un dispositivo SYMBYX. Los clientes también pueden tener estas condiciones de forma silenciosa sin ser conscientes de ellas. Siempre existe el riesgo de producir efectos secundarios no deseados, como náuseas, vómitos, mareos y vértigo leves y transitorios.  Si surgen estos síntomas, espere hasta que pasen. antes cambiando de posición con cuidado . Es importante reconocer estos síntomas, dejar de usar su dispositivo SYMBYX inmediatamente y buscar atención médica si los síntomas persisten. Si un cliente es consciente de dichas condiciones subyacentes antes de comenzar la fototerapia, se le recomienda comenzar con 1 a 2 semanas, la mitad de la dosis típica recomendada, bajo supervisión clínica*.

Requirements

Circumstance
Clinical Reasoning

Under medical care for diseases involving photosensitivity or receiving photosensitizing medications

Clinical Reasoning

These medications increase sensitivity to light therapy treatment.

Prescription medications (including for Parkinson’s)*

Clinical Reasoning

SYMBYX devices are designed to complement all pre-existing therapies.

Patients suffering from extreme sensitivity to light (incl vestibular migraine; epilepsy)

Clinical Reasoning

Risk of invoking a deleterious episode.

Pregnancy

Clinical Reasoning

Insufficient supporting evidence, even-though no negative episodes have been documented.

Heart conditions*

Clinical Reasoning

Light therapy might temporarily increase autonomic symptoms, including dizziness, light-headedness, tremor and heart rate. If this happens, patients should immediately contact Clinical Support at clinicalsupport@symbyxbiome.com.

Thrombosis including DVT

Clinical Reasoning

Insufficient supporting evidence, even though no negative episodes have been documented.  

Aneurysms (including intra-cerebral aneurysms and abdominoaortic aneurysms)

Clinical Reasoning

Light therapy might temporarily increase autonomic symptoms, including dizziness, light-headedness, tremor and heart rate. If this happens, patients should immediately contact Clinical Support at clinicalsupport@symbyxbiome.com.

Deep Brain Stimulation (DBS)

Clinical Reasoning

Insufficient supporting evidence, even-though no negative episodes have been documented.

History of acute psychiatric episodes, severe hypermobility (incl Ehlers Danlos); acute polyarthritic disorders*

Clinical Reasoning

Insufficient supporting evidence, even-though no negative episodes have been documented.

Hypermobility and polyarthritic conditions are often accompanied by dysautonomia.

Patient should commence a 1-2 week, half of recommended dosage under clinical supervision*.

Rheumatoid Arthritis*

Clinical Reasoning

Insufficient supporting evidence, even-though no negative episodes have been documented. Patient should commence a 1-2 week, half of recommended dosage under clinical supervision*.

Stroke or history of stroke or transient ischemic attack (TIA)

Clinical Reasoning

Light therapy improves circulation, which may cause further functional or structural deficit.

Tumour site (active primary or secondary)

Clinical Reasoning

Insufficient supporting evidence, even though no negative episodes have been documented. 

Acute head trauma and concussion

Clinical Reasoning

Internal bleeding may develop over the following days and weeks after a head trauma and may be asymptomatic. As light therapy improves circulation, this can cause further functional or structural deficit, even though no negative episodes have been documented.

Migraines*

Clinical Reasoning

Light therapy improves circulation, which may cause further functional or structural deficit during a migraine episode, even though no negative episodes have been documented.

Acute, severe head pain

Clinical Reasoning

Light therapy improves circulation, which may cause further functional or structural deficit during a migraine episode, even though no negative episodes have been documented.

Sunburn

Clinical Reasoning

Light therapy may cause further skin exacerbation.  

* The incidence of dysautonomia is a common complication in several disorders and has been observed in customers suffering from Parkinson’s, migraine, cervicogenic headaches, fibromyalgia, hypermobility syndromes, psychiatric disorders, Irritable Bowel Syndrome, epilepsy, and acute polyarthritic conditions. Symptoms may include dizziness, vertigo, nausea, low blood pressure, and visual disturbances. If dysautonomia symptoms are noted during the initial 2-4 treatments with a SYMBYX device, we recommend ceasing treatment and immediately contacting Clinical Support atclinicalsupport@symbyxbiome.com. Usually, these symptoms are transient and dissipate after a 3-5 day complete rest period, followed by gradual reintroduction of the therapy under clinical supervision. 

** Patient’s with a pacemaker should exercise extra caution and avoid placing the laser over their chest/heart region, even though no negative episodes have been documented. 

***Please do not treat directly over thyroid, glands, genitalia or eyes at any time. There is insufficient supporting evidence for the treatment of these regions.  

Clinical Support Team

Clinical Support Team

Our integrated team of clinicians of physiotherapists and chiropractors provide ongoing advice and support so that you get the most out of SYMBYX light therapy. Find guidance on when, where and precisely how to use the device, with access to an expert whenever you need. Why? Because you believe you deserve more.

REACH OUT TO CLINICAL SUPPORT TODAY

CONTACT THE TEAM TODAY